倍杰特(300774.SZ):簽訂3.82億元投建中水回用BOO項目的合作協議
格隆匯11月11日丨倍杰特(300774.SZ)公佈,公司與孟州市人民政府簽訂了《關於投資建設中水回用BOO項目的合作協議》,為孟州市城市中水及工業用水進行資源化再利用統籌規劃。該項目設計建設規模6萬方/天(遠景10萬方/天),中水來源為第一污水處理廠和第二污水處理廠及後期擴建污水處理廠的達標污水,最終產品水供應孟州市及周邊企業用水。項目佔地約40畝,總投資3.82億元人民幣。公司將在河南省孟州市註冊設立項目公司負責該項目投資、建設和運營,具體註冊資本及其他情況需進一步確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.